Description of Membership:
Membership in the Association consists of the following categories: (a) Full Membership: Full membership is open to innovative pharmaceutical Persons which research, develop, manufacture and/or distribute pharmaceutical prescription preparations under their own labels in Canada. (b) Biopharmaceutical Membership: Biopharmaceutical membership is open to Persons who are engaged, for profit, in research and development of pharmaceutical products and/or biopharmaceutical health care products with the aim of producing, manufacturing or distributing the same under its own label. (c) Medical Research Affiliate Members Membership: Medical research affiliate members membership is open to non-profit organizations engaged in activities that entitle such organizations to a deduction or tax credit for expenditures on scientific research and experimental development under the Income Tax Act (Canada) research, which have a relationship or are connected with hospitals, universities, research institutes, recognized health/disease organizations, or divisions or units thereof, whose membership, in the determination of the Board, would be consistent with the objects of the Association and would enhance the ability of the Association to attain such objects, and who are engaged in health research. (d) Associate Membership: Associate membership is open to Persons who do not qualify under any of the foregoing membership categories and whose membership, in the determination of the Board, would be consistent with the objects of the Association and would enhance the ability of the Association to attain such objects. 2024 BOARD OF DIRECTORS – As of March 22, 2024 Chair of the Board: Brigitte Nolet, President & CEO, Hoffmann-La Roche Ltd. Vice-Chair: Carol Stiff, Rhythm Pharmaceuticals Canada Inc. Treasurer: Lisa Mullett, General Manager, Sumitomo Pharma Canada, Inc. Officers: Ed Dybka, President and General Manager, Ipsen Biopharmaceuticals Canada, Inc. Jody Engel, Canada Country Manager, Knight Therapeutics Inc. Rute Fernandes, General Manager, Takeda Canada Inc. Vince Lamanna, President, Novo Nordisk Canada Inc. Christine Lennon,General Manager Canada, Incyte Biosciences Canada Elaine Phillips, General Manager, Bristol-Myers Squibb Canada Najah Sampson, President, Pfizer Canada Frank Stramaglia, General Manager, Astellas Pharma Canada, Inc. Stéphanie Veyrun-Manetti, General Manager Specialty Care and Country Lead Canada, Sanofi Canada Berkeley Vincent, President, Janssen Inc. Gaby Bourbara, President, AstraZeneca Canada, Inc. Jonathan Soong, General Manager, Amicus Therapeutics Canada Inc.